Compound febantel chewable tablet for dogs and cats
A technology of non-bantyr and chewable tablets, applied in the field of compound non-bantyr chewable tablets and its preparation, to achieve the effects of improving oral bioavailability, increasing compliance, and good taste
Inactive Publication Date: 2013-05-08
QINGDAO VLAND BIOTECH INC
View PDF0 Cites 1 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Changshanone is a new broad-spectrum anticoccidial drug, no adverse reactions have been found so far, and there is no cross-resistance with other anticoccidial drugs
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreExamples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0017] Prescription composition:
[0018] Febantyr 10mg
[0019] Praziquantel 5mg
[0020] Pyrantel 15mg
[0021] Hemosanone 5mg
[0022] Microcrystalline Cellulose 23mg
[0023] Starch 30mg
[0025] Beef Flavor 10mg
[0026] Total 100mg per tablet
[0027] Preparation method: praziquantel, pyrantel, febantyle, hemosanone, microcrystalline cellulose, and starch are respectively passed through a 100-mesh sieve, mixed evenly, made into a soft material with an appropriate amount of alcohol, granulated with a 20-mesh sieve, dried, and 20-mesh Sieve whole grains, add beef essence and magnesium stearate, mix well, and press into tablets to obtain.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More Abstract
The invention discloses a compound febantel chewable tablet for dogs and cats. The active ingredients of the chewable tablet include praziquantel, pyrantel, febantel and halofuginone. The chewable tablet overcomes the characteristic of poor palatability of traditional tablets, can enable dogs and cats to chew drugs fully, and can ensure that the drugs are fully absorbed and good efficacy can be brought into play. The tablet provided in the invention comprises, by mass: 10%-20% of febantel, 5%-10% of praziquantel, 15%-25% of pyrantel, 5%-10% of halofuginone, 30%-50% of a filling agent, 0.5%-3% of a binder, and 5%-15% of a flavoring agent. The preparation process of the chewable tablet provided in the invention is simple, and can prepare the product with good taste and stable quality, thus being suitable for industrialized production.
Description
technical field [0001] The invention relates to a compound febantyr chewable tablet for expelling nematodes, tapeworms and protozoa in dogs and cats and a preparation method thereof. Background technique [0002] At present, there are many medicines for treating nematodes and tapeworms in dogs and cats in the pet market, but due to the serious mixed feeling of parasites in pets, there is currently a lack of antiparasitic medicines on the market that can treat nematodes, tapeworms and protozoa at the same time. Therefore, we have developed a highly efficient, comprehensive and safe antiparasitic drug. Its main ingredients include Praziquantel, Pyrantel, Febental and Halofuginone. Praziquantel is clinically effective against Schistosomiasis japonicum, Taeniasis, Clonorchiasis, and Paragonimiasis. Pyrantel is mainly used clinically to drive away roundworms, hookworms, and pinworms. Febantyr is a benzimidazole precursor anthelmintic, which has been approved in the United Sta...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More IPC IPC(8): A61K31/517A61K31/506A61K31/4985A61K31/27A61K9/20A61P33/00A61P33/02
Inventor 郝智慧张瑞丽王艳玲
Owner QINGDAO VLAND BIOTECH INC
